Ohmagari N - Search Results

1

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation.

Safdar A, Rodriguez G, Ohmagari N, Kontoyiannis DP, Rolston KV, Raad II, Champlin RE. Safdar A, et al. Among authors: ohmagari n. Cancer. 2005 Feb 15;103(4):731-9. doi: 10.1002/cncr.20883. Cancer. 2005. PMID: 15641032 Free article.

2

Invasive aspergillosis in patients with solid tumors.

Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Ohmagari N, et al. Cancer. 2004 Nov 15;101(10):2300-2. doi: 10.1002/cncr.20647. Cancer. 2004. PMID: 15452832 Free article.

3

Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.

Ohmagari N, Hanna H, Graviss L, Hackett B, Perego C, Gonzalez V, Dvorak T, Hogan H, Hachem R, Rolston K, Raad I. Ohmagari N, et al. Cancer. 2005 Jul 1;104(1):205-12. doi: 10.1002/cncr.21115. Cancer. 2005. PMID: 15880433 Free article.

4

[Infection prevention strategy for antimicrobial-resistant organisms].

Ohmagari N. Ohmagari N. Gan To Kagaku Ryoho. 2012 Feb;39(2):162-4. Gan To Kagaku Ryoho. 2012. PMID: 22333625 Japanese.

5

Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient.

Hayakawa K, Takasaki T, Tsunemine H, Kanagawa S, Kutsuna S, Takeshita N, Mawatari M, Fujiya Y, Yamamoto K, Ohmagari N, Kato Y. Hayakawa K, et al. Among authors: ohmagari n. Int J Infect Dis. 2015 Aug;37:9-10. doi: 10.1016/j.ijid.2015.05.025. Epub 2015 Jun 9. Int J Infect Dis. 2015. PMID: 26068870 Free article.

6

Trends of Antifungal Use Based on Sales Data in Japan from 2006 to 2015.

Kawabe A, Muraki Y, Inose R, Kusama Y, Goto R, Ebisui A, Ishii S, Ishikane M, Ohge H, Ohmagari N. Kawabe A, et al. Among authors: ohmagari n. Biol Pharm Bull. 2020;43(8):1248-1252. doi: 10.1248/bpb.b20-00302. Biol Pharm Bull. 2020. PMID: 32741945 Free article.

7

In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.

Araoka H, Baba M, Tateda K, Ishii Y, Oguri T, Okuzumi K, Oishi T, Mori S, Mitsuda T, Moriya K, Nakamori Y, Ohmagari N, Yamaguchi K, Yoneyama A; ABX Combination Therapy Study Group. Araoka H, et al. Among authors: ohmagari n. Jpn J Infect Dis. 2012;65(1):84-7. Jpn J Infect Dis. 2012. PMID: 22274165 Free article.

8

Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6')-Iae/AAC(6')-Ib.

Tojo M, Tada T, Shimojima M, Tanaka M, Narahara K, Miyoshi-Akiyama T, Kirikae T, Ohmagari N. Tojo M, et al. Among authors: ohmagari n. J Infect Chemother. 2014 Sep;20(9):586-8. doi: 10.1016/j.jiac.2014.04.014. Epub 2014 Jun 6. J Infect Chemother. 2014. PMID: 24910373

9

Multidrug-Resistant Sequence Type 235 Pseudomonas aeruginosa Clinical Isolates Producing IMP-26 with Increased Carbapenem-Hydrolyzing Activities in Vietnam.

Tada T, Nhung PH, Miyoshi-Akiyama T, Shimada K, Tsuchiya M, Phuong DM, Anh NQ, Ohmagari N, Kirikae T. Tada T, et al. Among authors: ohmagari n. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6853-6858. doi: 10.1128/AAC.01177-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27600046 Free PMC article.

10

High rate of multidrug-resistant organism colonization among patients hospitalized overseas highlights the need for preemptive infection control.

Hayakawa K, Mezaki K, Sugiki Y, Nagamatsu M, Miyoshi-Akiyama T, Kirikae T, Kutsuna S, Takeshita N, Yamamoto K, Katanami Y, Ohmagari N. Hayakawa K, et al. Among authors: ohmagari n. Am J Infect Control. 2016 Nov 1;44(11):e257-e259. doi: 10.1016/j.ajic.2016.06.040. Am J Infect Control. 2016. PMID: 27810070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page